Melanoma, a serious skin cancer starting from pigment cells, can spread and become metastatic, making it dangerous. Cases have been rising, with the WHO predicting over 424,000 cases and 94,000 deaths by 2035. Bristol Myers Squibb’s CheckMate -067 trial showed that combining Opdivo and Yervoy significantly improves survival rates for advanced melanoma, with 43% of patients alive at 10 years.
Advances in treating Melanoma
Opdivo & Yervoy's success in Melanoma.
Explore more ..
Kimchi Bacteria May Help Flush Nanoplastics from the Body
The discovery points to an unexpected connection between a traditional fermented food and one of the most pressing concerns in modern environmental health.
High-fat diets and memory loss- A reversible story
Machine learning identifies early depression signals in facial patterns.
Why alcohol halts liver regeneration, even after quitting
New research links inflammation to faulty RNA processing
Breakthrough stool test could replace invasive colonoscopies
An artificial intelligence-based approach to diagnose colorectal cancer from the gut microbiota.
